ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.05
-0.01 (-0.11%)
At close: Mar 9, 2026, 4:00 PM EDT
9.07
+0.02 (0.22%)
After-hours: Mar 9, 2026, 6:38 PM EDT
ARS Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -171.3 | 8 | -54.37 | -34.68 | -20.24 | |
| Depreciation & Amortization | 1.37 | 0.08 | 0.07 | 0.03 | 0.21 | |
| Asset Writedown & Restructuring Costs | - | - | - | 1.06 | - | |
| Loss (Gain) From Sale of Investments | -5.52 | -7.25 | -6.85 | 0.29 | - | |
| Stock-Based Compensation | 22.1 | 14.53 | 9.24 | 5.84 | 2.83 | |
| Other Operating Activities | 2.5 | - | - | 0.14 | -0 | |
| Change in Accounts Receivable | -17.21 | -8.18 | - | - | - | |
| Change in Inventory | -21.99 | -5.95 | - | - | - | |
| Change in Accounts Payable | 18.88 | 16.43 | -2.78 | -10.29 | 0.97 | |
| Change in Unearned Revenue | -0.35 | 2.09 | -3.14 | -1.32 | -2.51 | |
| Change in Other Net Operating Assets | 0.66 | -6.21 | -1.45 | -1.15 | 1.18 | |
| Operating Cash Flow | -170.87 | 13.55 | -59.27 | -40.08 | -17.56 | |
| Capital Expenditures | -0.34 | -0.56 | -0.18 | -0.2 | -0.06 | |
| Investment in Securities | 64.97 | -98.04 | -87.01 | - | - | |
| Other Investing Activities | -7.86 | -7.5 | - | - | - | |
| Investing Cash Flow | 56.77 | -106.1 | -87.18 | -0.2 | -0.06 | |
| Long-Term Debt Issued | 96.26 | 69.38 | - | - | - | |
| Long-Term Debt Repaid | - | - | - | -8.68 | -1.82 | |
| Net Debt Issued (Repaid) | 96.26 | 69.38 | - | -8.68 | -1.82 | |
| Issuance of Common Stock | 5.68 | 3.02 | 6.9 | 0.57 | 0.17 | |
| Other Financing Activities | 2.66 | - | - | 198.84 | - | |
| Financing Cash Flow | 104.6 | 72.4 | 6.9 | 190.73 | 53.16 | |
| Net Cash Flow | -9.5 | -20.15 | -139.55 | 150.46 | 35.54 | |
| Free Cash Flow | -171.21 | 12.99 | -59.44 | -40.28 | -17.62 | |
| Free Cash Flow Margin | -203.14% | 14.57% | -198136.67% | -3060.56% | -319.94% | |
| Free Cash Flow Per Share | -1.74 | 0.13 | -0.62 | -1.01 | -0.61 | |
| Cash Interest Paid | 2.45 | - | - | 0.37 | 0.58 | |
| Levered Free Cash Flow | -116.64 | 16.46 | -36.17 | -17.86 | -9.57 | |
| Unlevered Free Cash Flow | -115.02 | 16.46 | -36.17 | -17.86 | -9.07 | |
| Change in Working Capital | -20 | -1.81 | -7.36 | -12.75 | -0.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.